Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Learn about the best cash back rewards cards that come with no fees. Maximize your benefits today!
23,366 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
VFVA has posted solid gains by targeting cheap U.S. equities, but a hidden volatility risk lies in its deep value app...
Investors often wonder if the memory chip darling Micron is still worth buying after a big run. This guide breaks dow...
In today’s Morning Minute: Crypto Majors, a squeeze in liquidity meets geopolitical headlines, pushing major crypto a...
A high-profile moment on television can ripple through a star's bank account. This article dissects what the Barkley ...
As Micron Technology rides AI-driven memory demand, investors debate a bold forecast. Market models suggest a potenti...
With stock markets choppy and inflation easing, a growing number of financial planners urge a bridge strategy: withdr...
At age 65, Health Savings Accounts shift from a pure medical fund to a hybrid tool that can rival a 401(k) for non-me...
Sprinklr has seen a steep slide, slipping about 40% over the past year. A large fund recently sold close to $3 millio...
A multi-jurisdictional probe led to indictments for 62 people connected to a massive crypto-laundering operation. The...
Markets showed modest gains as the Fed meeting kicked off, with tech and travel shares helping lift indexes. This gui...
A landmark innovator, Ted Turner reshaped TV by launching CNN, expanding cable, and preserving Hollywood classics. Th...